[HTLV-III serology, epidemiology and clinical aspects of imprisoned i.v. drug-dependent males in Austria].
Sera of 71 intravenous drug abusers imprisoned in Austria were tested for HTLV-III antibodies and the results correlated with the case histories and available clinical data. 12 sera, i.e. 17%, were found to be positive. Seronegative and seropositive drug addicts showed no notable difference regarding the average duration of previous drug abuse or the incidence of sexually-transmitted diseases. Among HTLV-III seropositive drug addicts there was found to be a significantly higher incidence of frequent needle-sharing and history of previous i.v. drug abuse in Amsterdam. 6 of 12 HTLV-III seropositive drug addicts had developed the lymphadenopathy syndrome (LAS); chronic liver disease and positive hepatitis B serology were equally frequent in HTLV-III seronegative persons, HTLV-III seropositive persons without symptoms and LAS patients.
D000163:Acquired Immunodeficiency Syndrome / Q000175:diagnosis / Q000276:immunology*; D000328:Adult; D000914:Antibodies, Viral / Q000032:analysis*; D001317:Austria; D003430:Cross-Sectional Studies; D017977:Deltaretrovirus; D015483:HIV Antibodies; D006509:Hepatitis B / Q000276:immunology; D006510:Hepatitis B Antibodies / Q000032:analysis; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D011329:Prisoners; D012192:Retroviridae Infections / Q000175:diagnosis / Q000276:immunology*; D019966:Substance-Related Disorders / Q000150:complications*
D000914:Antibodies, Viral; D015483:HIV Antibodies; D006510:Hepatitis B Antibodies
HTLV-III-Serologie, Epidemiologie und Klinik inhaftierter i. v. drogenabhängiger Männer in Osterreich.